Vaccination is significant to control, mitigate, and recover from the destructive effects of
coronavirus disease 2019 (COVID-19). The incidence of myocarditis following COVID-19 …

Background. Coronavirus 2019 (COVID‐19) was initially identified approximately in
December 2019 at Wuhan, China, as patients presented with vague prodromal and …

Introduction Reports of SARS-CoV-2 coronavirus (COVID-19) vaccine-related myocarditis,
particularly after mRNA vaccines, have raised concerns amongst the general public. This …

Following mass vaccinations for the control of the COVID-19 epidemic, a spectrum of cardiac
and neurological disorders was reported among vaccinated individuals. This study …

Case reports of myocarditis post-coronavirus disease 2019 (COVID-19) mRNA vaccination
have not uniformly reported long-term follow-up beyond 90 days. We present a 23-year-old …

As we enter a new era of mRNA‐based therapeutics, evidence on genetic or environmental
factors that might predispose to unknown off‐target side effects, gains in importance. Among …

Myocarditis is being increasingly reported as a rare complication of coronavirus disease
2019 (COVID-19) mRNA vaccines. We herein report a case of myocarditis following COVID …

METHODS We searched the database of PubMed, Embase, and Cochrane for all possible
cardiac adverse events reported after COVID-19 vaccination using the following search …

Abstract Background Coronavirus disease 2019 (COVID-19) mRNA vaccine–associated
acute myocarditis has been well described, and the demonstration of elevated high …

We present the case of a 41-year-old man who developed myopericarditis after receiving the
Pfizer COVID-19 vaccine. The patient experienced a sudden onset of chest and abdominal …